A team led by Prof. Dr. Markus Damme of Bielefeld University and Prof. Volker Haucke, director of the Leibniz-Forschungsinstitut fur Molekulare Pharmakologie in Berlin, has identified the protein that shuts down one of the cell's central transport switches. The switch in question is ARL8B, which works like a motor starter: when it is active, lysosomes travel along microtubules, the cell's internal rail network, out to the periphery, where they promote growth. How that signal was turned off again had not been established until now.
The answer, according to the researchers, is a protein called TBC1D9B. It binds to the lysosomal membrane protein TMEM55B and inactivates ARL8B through what biochemists call a GAP function, short for GTPase-activating protein - a standard mechanism for returning molecular switches to their resting state. The work was carried out jointly by the Berlin and Bielefeld groups together with researchers at Christian-Albrechts-Universitat Kiel.
Why this matters comes down to what lysosomes do. They are the metabolic control centers of cells and tissues, including in the brain, breaking down defective proteins and other large molecules into reusable building blocks, and deciding whether a cell grows or shifts into an energy-saving mode. Their position inside the cell is part of that decision. "This gives us a better understanding of how cells spatially organize their recycling centers - or, more specifically, their sustainability centers - and adapt them to nutrient deprivation," Haucke said.
Because failures of lysosomal function and protein clearance sit close to the biology of neurodegenerative disease, mapping the on and off controls of lysosome positioning fills in a piece of basic cell biology that disease research depends on. This is mechanistic groundwork rather than a treatment finding, but knowing which protein flips the switch off gives researchers a defined target to study when lysosomal regulation goes wrong.